Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy

by Aura Muntasell, Mariona Cabo, Sonia Servitja, Sonia Servitja, Ignasi Tusquets, Ignasi Tusquets, María Martínez-García, María Martínez-García, Ana Rovira, Ana Rovira, Federico Rojo, Joan Albanell, Joan Albanell, Joan Albanell, Miguel López-Botet, Miguel López-Botet
Published 2017-11-01

Thromboembolic, cardiovascular and overall mortality risks of aromatase inhibitors, compared with tamoxifen treatment: an outpatient-register-based retrospective cohort study

by Marta Pineda-Moncusí, Natalia Garcia-Giralt, Adolfo Diez-Perez, Ignasi Tusquets, Sonia Servitja, Joan Albanell, Daniel Prieto-Alhambra, Xavier Nogués
Published 2020-03-01

MicroRNA-33b Suppresses Epithelial–Mesenchymal Transition Repressing the MYC–EZH2 Pathway in HER2+ Breast Carcinoma

by Birlipta Pattanayak, Iris Garrido-Cano, Anna Adam-Artigues, Eduardo Tormo, Eduardo Tormo, Begoña Pineda, Begoña Pineda, Begoña Pineda, Paula Cabello, Elisa Alonso, Elisa Alonso, Begoña Bermejo, Begoña Bermejo, Begoña Bermejo, Cristina Hernando, Cristina Hernando, María Teresa Martínez, María Teresa Martínez, Ana Rovira, Ana Rovira, Joan Albanell, Joan Albanell, Joan Albanell, Federico Rojo, Federico Rojo, Octavio Burgués, Octavio Burgués, Juan Miguel Cejalvo, Juan Miguel Cejalvo, Ana Lluch, Ana Lluch, Ana Lluch, Ana Lluch, Pilar Eroles, Pilar Eroles, Pilar Eroles
Published 2020-09-01

The Novel Oral mTORC1/2 Inhibitor TAK-228 Reverses Trastuzumab Resistance in HER2-Positive Breast Cancer Models

by Marta Sanz-Álvarez, Ester Martín-Aparicio, Melani Luque, Sandra Zazo, Javier Martínez-Useros, Pilar Eroles, Ana Rovira, Joan Albanell, Juan Madoz-Gúrpide, Federico Rojo
Published 2021-06-01

Expression of Phosphorylated BRD4 Is Markedly Associated with the Activation Status of the PP2A Pathway and Shows AStrong Prognostic Value in Triple Negative Breast Cancer Patients

by Marta Sanz-Álvarez, Ion Cristóbal, Melani Luque, Andrea Santos, Sandra Zazo, Juan Madoz-Gúrpide, Cristina Caramés, Cheng-Ming Chiang, Jesús García-Foncillas, Pilar Eroles, Joan Albanell, Federico Rojo
Published 2021-03-01

Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer.

by Julia Inglés-Esteve, Mònica Morales, Alba Dalmases, Ricard Garcia-Carbonell, Alba Jené-Sanz, Núria López-Bigas, Mar Iglesias, Cristina Ruiz-Herguido, Ana Rovira, Federico Rojo, Joan Albanell, Roger R Gomis, Anna Bigas, Lluís Espinosa
Published 2012-01-01

Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations

by David Tamborero, Carlota Rubio-Perez, Jordi Deu-Pons, Michael P. Schroeder, Ana Vivancos, Ana Rovira, Ignasi Tusquets, Joan Albanell, Jordi Rodon, Josep Tabernero, Carmen de Torres, Rodrigo Dienstmann, Abel Gonzalez-Perez, Nuria Lopez-Bigas
Published 2018-03-01

Serum cytokine levels as predictive biomarkers of benefit from ipilimumab in small cell lung cancer

by Max Hardy-Werbin, Pedro Rocha, Oriol Arpi, Álvaro Taus, Lara Nonell, Xavier Durán, Xavier Villanueva, Deborah Joseph-Pietras, Luke Nolan, Sarah Danson, Richard Griffiths, Miguel Lopez-Botet, Ana Rovira, Joan Albanell, Christian Ottensmeier, Edurne Arriola
Published 2019-06-01

Manic Fringe deficiency imposes Jagged1 addiction to intestinal tumor cells

by Erika López-Arribillaga, Verónica Rodilla, Carlota Colomer, Anna Vert, Amy Shelton, Jason H. Cheng, Bing Yan, Abel Gonzalez-Perez, Melissa R. Junttila, Mar Iglesias, Ferran Torres, Joan Albanell, Alberto Villanueva, Anna Bigas, Christian W. Siebel, LLuís Espinosa
Published 2018-07-01

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth

by Felipe Slebe, Federico Rojo, Maria Vinaixa, Mar García-Rocha, Giorgia Testoni, Marc Guiu, Evarist Planet, Sara Samino, Enrique J. Arenas, Antoni Beltran, Ana Rovira, Ana Lluch, Xavier Salvatella, Oscar Yanes, Joan Albanell, Joan J. Guinovart, Roger R. Gomis
Published 2016-04-01

Snail1 Expression Is Required for Sarcomagenesis

by Lorena Alba-Castellón, Raquel Batlle, Clara Francí, María J. Fernández-Aceñero, Rocco Mazzolini, Raúl Peña, Jordina Loubat, Francesc Alameda, Rufo Rodríguez, Josué Curto, Joan Albanell, Alberto Muñoz, Félix Bonilla, J. Ignacio Casal, Federico Rojo, Antonio García de Herreros
Published 2014-05-01

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer

by Beth O. Van Emburgh, Sabrina Arena, Giulia Siravegna, Luca Lazzari, Giovanni Crisafulli, Giorgio Corti, Benedetta Mussolin, Federica Baldi, Michela Buscarino, Alice Bartolini, Emanuele Valtorta, Joana Vidal, Beatriz Bellosillo, Giovanni Germano, Filippo Pietrantonio, Agostino Ponzetti, Joan Albanell, Salvatore Siena, Andrea Sartore-Bianchi, Federica Di Nicolantonio, Clara Montagut, Alberto Bardelli
Published 2016-12-01

The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer

by Paula González-Alonso, Sandra Zazo, Ester Martín-Aparicio, Melani Luque, Cristina Chamizo, Marta Sanz-Álvarez, Pablo Minguez, Gonzalo Gómez-López, Ion Cristóbal, Cristina Caramés, Jesús García-Foncillas, Pilar Eroles, Ana Lluch, Oriol Arpí, Ana Rovira, Joan Albanell, Sander R. Piersma, Connie R. Jimenez, Juan Madoz-Gúrpide, Federico Rojo
Published 2020-04-01